These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21116481)

  • 1. Challenges and opportunities for new protein crystallization strategies in structure-based drug design.
    Grey JL; Thompson DH
    Expert Opin Drug Discov; 2010 Nov; 5(11):1039-45. PubMed ID: 21116481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using X-ray crystallography in drug discovery.
    Rowland RS
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein crystallization for structure-based drug design.
    Hoffman ID
    Methods Mol Biol; 2012; 841():67-91. PubMed ID: 22222449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug design: aiming for a perfect fit.
    van Montfort RLM; Workman P
    Essays Biochem; 2017 Nov; 61(5):431-437. PubMed ID: 29118091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iterative screen optimization maximizes the efficiency of macromolecular crystallization.
    Jones HG; Wrapp D; Gilman MSA; Battles MB; Wang N; Sacerdote S; Chuang GY; Kwong PD; McLellan JS
    Acta Crystallogr F Struct Biol Commun; 2019 Feb; 75(Pt 2):123-131. PubMed ID: 30713164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study.
    Argiriadi MA; Sousa S; Banach D; Marcotte D; Xiang T; Tomlinson MJ; Demers M; Harris C; Kwak S; Hardman J; Pietras M; Quinn L; DiMauro J; Ni B; Mankovich J; Borhani DW; Talanian RV; Sadhukhan R
    BMC Struct Biol; 2009 Mar; 9():16. PubMed ID: 19296855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization to obtain protein-ligand complexes for structure-aided drug design.
    Danley DE
    Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):569-75. PubMed ID: 16699182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of crystallography in drug discovery.
    Zheng H; Hou J; Zimmerman MD; Wlodawer A; Minor W
    Expert Opin Drug Discov; 2014 Feb; 9(2):125-37. PubMed ID: 24372145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
    Argiriadi MA; Goedken ER; Banach D; Borhani DW; Burchat A; Dixon RW; Marcotte D; Overmeyer G; Pivorunas V; Sadhukhan R; Sousa S; Moore NS; Tomlinson M; Voss J; Wang L; Wishart N; Woller K; Talanian RV
    BMC Struct Biol; 2012 Sep; 12():22. PubMed ID: 22995073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein crystallization.
    Deivanayagam C; Cook WJ; Walter MR
    Methods Mol Biol; 2007; 383():337-49. PubMed ID: 18217696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of protein crystals for X-ray structural study.
    Takeda S
    Methods Mol Med; 2006; 129():291-303. PubMed ID: 17085819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent applications of protein crystallography and structure-guided drug design.
    Williams SP; Kuyper LF; Pearce KH
    Curr Opin Chem Biol; 2005 Aug; 9(4):371-80. PubMed ID: 16006182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in α-helical membrane protein crystallization: an update.
    Parker JL; Newstead S
    Protein Sci; 2012 Sep; 21(9):1358-65. PubMed ID: 22811290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New trends in macromolecular X-ray crystallography.
    Wery JP; Schevitz RW
    Curr Opin Chem Biol; 1997 Oct; 1(3):365-9. PubMed ID: 9667874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Crystal Growth for Neutron Macromolecular Crystallography.
    Vahdatahar E; Junius N; Budayova-Spano M
    J Vis Exp; 2021 Mar; (169):. PubMed ID: 33779594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of soluble and membrane protein structures by X-ray crystallography.
    Lieberman RL; Peek ME; Watkins JD
    Methods Mol Biol; 2013; 955():475-93. PubMed ID: 23132076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput crystallization and structure determination in drug discovery.
    Stewart L; Clark R; Behnke C
    Drug Discov Today; 2002 Feb; 7(3):187-96. PubMed ID: 11815235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practices in Molecular Docking and Structure-Based Virtual Screening.
    Dos Santos RN; Ferreira LG; Andricopulo AD
    Methods Mol Biol; 2018; 1762():31-50. PubMed ID: 29594766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein crystallization for X-ray crystallography.
    Dessau MA; Modis Y
    J Vis Exp; 2011 Jan; (47):. PubMed ID: 21304455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.